These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

945 related items for PubMed ID: 24857696

  • 1. Volumetric-modulated arc radiotherapy for pancreatic malignancies: dosimetric comparison with sliding-window intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
    Nabavizadeh N, Simeonova AO, Waller JG, Romer JL, Monaco DL, Elliott DA, Tanyi JA, Fuss M, Thomas CR, Holland JM.
    Med Dosim; 2014; 39(3):256-60. PubMed ID: 24857696
    [Abstract] [Full Text] [Related]

  • 2. Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for pancreatic malignancies.
    Ali AN, Dhabaan AH, Jarrio CS, Siddiqi AK, Landry JC.
    Med Dosim; 2012; 37(3):271-5. PubMed ID: 22189026
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy.
    Lin CY, Huang WY, Jen YM, Chen CM, Su YF, Chao HL, Lin CS.
    Dis Esophagus; 2014 Aug; 27(6):585-90. PubMed ID: 24134466
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs. 3D-CRT and intensity-modulated radiotherapy.
    Haertl PM, Pohl F, Weidner K, Groeger C, Koelbl O, Dobler B.
    Med Dosim; 2013 Aug; 38(1):1-4. PubMed ID: 22727550
    [Abstract] [Full Text] [Related]

  • 9. 18 F-Fluoromisonidazole positron emission tomography/CT-guided volumetric-modulated arc therapy-based dose escalation for hypoxic subvolume in nasopharyngeal carcinomas: A feasibility study.
    Qiu J, Lv B, Fu M, Wang X, Zheng X, Zhuo W.
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer.
    Cilla S, Caravatta L, Picardi V, Sabatino D, Macchia G, Digesù C, Deodato F, Massaccesi M, De Spirito M, Piermattei A, Morganti AG.
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):261-8. PubMed ID: 21820294
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of whole-field simultaneous integrated boost VMAT and IMRT in the treatment of nasopharyngeal cancer.
    Jin X, Yi J, Zhou Y, Yan H, Han C, Xie C.
    Med Dosim; 2013 May; 38(4):418-23. PubMed ID: 23973017
    [Abstract] [Full Text] [Related]

  • 15. Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: a planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique.
    Nguyen BT, Hornby C, Kron T, Cramb J, Rolfo A, Pham D, Haworth A, Tai KH, Foroudi F.
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):211-9. PubMed ID: 22498196
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pancreatic cancer planning: Complex conformal vs modulated therapies.
    Chapman KL, Witek ME, Chen H, Showalter TN, Bar-Ad V, Harrison AS.
    Med Dosim; 2016 Apr; 41(2):100-4. PubMed ID: 26831922
    [Abstract] [Full Text] [Related]

  • 19. A comparison of volumetric modulated arc therapy and sliding-window intensity-modulated radiotherapy in the treatment of Stage I-II nasal natural killer/T-cell lymphoma.
    Liu X, Yang Y, Jin F, He Y, Zhong M, Luo H, Qiu D, Li C, Yang H, He G, Wang Y.
    Med Dosim; 2016 Apr; 41(1):42-6. PubMed ID: 26428072
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.